| Code | 6198D | ||||||||||
| MA number | 68/0275/20-S | ||||||||||
| Product Form: | plu igf 2x25 mg+2x2 ml vehik. (liek.inj.skl.+striek.inj.skl.+adaptér+ 2 ihly) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | vial glass and pre-filled syringe glass | ||||||||||
| Route of admin.: | Intramuscular use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.12.2020 |
| Validity: | 21.12.2025 |
| SPC: |
SPC_Risperidon Teva plu igf_03.2022.pdf
|
| PIL: |
PIL_Risperidon Teva plu igf_03.2022.pdf
|
| Safety feature | Yes |
| Data update: | 15.12.2021 |
